NFT: Test, Amphetamine, Over The Counter

Product code NFT, “Test, Amphetamine, Over The Counter” in FDA's classification database, is a Class II device type under 21 CFR 862.3100 (amphetamine test system), reviewed by FDA's Clinical Toxicology panel. FDA's 510(k) database lists 32 clearances under NFT, 32 of them since 2011.
Updated Oct 29, 2026 · Clearances from FDA’s 510(k) database, as of Oct 29, 2026
Product code
NFT
Regulation
21 CFR 862.3100
Class
II
Panel
Clinical Toxicology
Clearances
32
Most recent
Sep 10, 2026
Median review, last 2 years
35 days
Third-party review
Eligible
Implant
No

What it covers

An amphetamine test system is a device intended to measure amphetamine, a central nervous system stimulating drug, in plasma and urine. Measurements obtained by this device are used in the diagnosis and treatment of amphetamine use or overdose and in monitoring levels of amphetamine to ensure appropriate therapy.

The identification in 21 CFR 862.3100, amphetamine test system. FDA gives NFT no definition of its own, so the regulation’s describes it.

Recent clearances

510(k)DeviceApplicantDecisionType
K261409BioTeke® Multi-Drug Urine Test CupBioteke Corporation (Wuxi) Co., Ltd.Sep 10, 2026Traditional
K261984AssureTech Quick Cup Tests;AssureTech Multi-drug Urine Test CupAssure Tech., LLCJul 17, 2026Traditional
K261280BioSieve Multi-Drug Urine Test Panel;BioSieve Multi-Drug Urine Home Test PanelVivachek Biotech (Hangzhou) Co., Ltd.May 22, 2026Traditional
K260065SAFElife T-Dip Multi-Drug Urine Test Panel; SAFElife T-Dip Multi-Drug Urine Test Panel DxGuangzhou Wondfo Biotech Co., Ltd.Apr 28, 2026Traditional
K260355Webest Multi-Drug Urine Cup; Webest Home Multi-Drug Urine CupWEBEST Biotech,, LLCMar 9, 2026Traditional
K252550SAFElife T-Cup Multi-Drug Urine Test Cup; SAFElife T-Cup Multi-Drug Urine Test Cup DxGuangzhou Wondfo Biotech Co., Ltd.Nov 18, 2025Traditional
K252867VINScreen Urine Drug Test Cup; VINScreen Urine Drug Home Test CupAdvin Biotech, Inc.Oct 9, 2025Traditional
K252554Wisdiag Multi-Drug Urine Test Cup; Wisdiag Multi-Drug Urine Home Test CupVivachek Biotech (Hangzhou) Co., Ltd.Sep 12, 2025Traditional
K252118CLUNGENE Multi-Drug Test Easy Cup; CLUNGENE Multi-Drug Home Test Easy CupHangzhou Clongene Biotech Co., Ltd.Aug 27, 2025Traditional
K252259AssureTech Quick Cup Tests; AssureTech Multi-drug Urine Test CupAssure Tech., LLCAug 15, 2025Traditional
From FDA’s 510(k) database, as of Oct 29, 2026Export CSV (100 rows free · all 32 with a free account)

Clearances by year

32 NFT 510(k)s were cleared from 2011 to Oct 29, 2026. Days to decision run from the day FDA received the 510(k) to its decision, including time on hold.

YearClearancesMedian days to decision
2026 (so far)535
2025837
2024431
2023137
2022363
20211209
2020226
2019129
2018656
20171117

Who submits

15 applicants cleared a NFT device since 2011. 69% of the clearances went to applicants in China, then United States (25%) and Canada (6%). By type: Traditional 100%.

ApplicantClearances since 2011
Guangzhou Wondfo Biotech Co., Ltd.4
Hangzhou AllTest Biotech Co., Ltd.4
Vivachek Biotech (Hangzhou) Co., Ltd.4
Assure Tech. (Hangzhou) Co, Ltd.3
Assure Tech., LLC3
Safecare Biotech (Hangzhou) Co., Ltd.3
Aicheck Biotech, Inc.2
Healstone Biotech, Inc.2

How FDA classifies it

Class II (special controls). An amphetamine test system is not exempt if it is intended for any use other than employment or insurance testing. The device is exempt from the premarket notification procedures in subpart E of part 807 of this chapter subject to the limitations in § 862.9, provided the test system is intended for employment and insurance testing and includes a statement in the labeling that the device is intended solely for use in employment and insurance testing.

From 21 CFR 862.3100. Special controls are the requirements a 510(k) must show it meets.

Standards

21 CFR 862.3100 names no consensus standards. Check FDA’s recognized standards database, or ask which standards recent NFT clearances declared.

Ask about NFT

US FDA devices: 510(k), De Novo, guidance, 21 CFR

Questions about NFT

What is FDA product code NFT?

Product code NFT, “Test, Amphetamine, Over The Counter” in FDA's classification database, is a Class II device type under 21 CFR 862.3100 (amphetamine test system), reviewed by FDA's Clinical Toxicology panel. FDA's 510(k) database lists 32 clearances under NFT, 32 of them since 2011.

How many 510(k) clearances are there under NFT?

FDA’s 510(k) database listed 32 clearances under NFT as of Oct 29, 2026, 32 of them decided since 2011; the most recent decision was Sep 10, 2026. The Predicate Finder searches the live database.

How long does FDA take to clear a NFT 510(k)?

For the 13 NFT clearances decided in the two years before Oct 29, 2026, the median time from FDA receiving the 510(k) to its decision was 35 days. That counts calendar days, including time the submission was on hold waiting for answers from the submitter.

Which companies have the most NFT clearances?

Since 2011: Guangzhou Wondfo Biotech Co., Ltd. (4), Hangzhou AllTest Biotech Co., Ltd. (4), Vivachek Biotech (Hangzhou) Co., Ltd. (4), Assure Tech. (Hangzhou) Co, Ltd. (3) and Assure Tech., LLC (3). 15 applicants have cleared a NFT device in that time.

Sources

  1. FDA product classification: NFT · Product Classification database
  2. 21 CFR 862.3100: Amphetamine test system · eCFR, as of Oct 27, 2026
  3. openFDA 510(k) query for NFT · run Oct 29, 2026
  4. 510(k) Premarket Notification database · FDA, accessdata.fda.gov
Follow NFTGet an email when FDA clears, recalls or publishes guidance for NFT devices.

Know what FDA already cleared.